Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study

References

• Bright D, Worley M, Porter BL. Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Social Adm Pharm. 2021;17(4):744–749.
   PubMed Web of Science ®Google Scholar
• Papastergiou J, Tolios P, Li W, Li J. The innovative Canadian pharmacogenomic screening initiative in community pharmacy (ICANPIC) study. J Am Pharm Assoc. 2017;57(5):624–629
   Google Scholar
• Bright DR, Kisor DF, Smith A, Conaway M, Yu M. Implementation of a pharmacogenetic management service for postmyocardial infarction care in a community pharmacy. Pers Med. 2015;12(4):319–325.
   PubMed Web of Science ®Google Scholar
• Kisor DF, Petry NJ, Bright DR. Pharmacogenomics in the United States community pharmacy setting: the clopidogrel-CYP2C19 example. Pharmacogenomics Pers Med. 2021;14:569.
   PubMed Web of Science ®Google Scholar
• Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, Noyce P, Sketris I. From, “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–639.
   PubMed Web of Science ®Google Scholar
• Breaux S, Desrosiers FA, Neira M, Sinha S, Nislow C. Pharmacogenomics at the point of care: a community pharmacy project in British Columbia. J Pers Med. 2021;11(1):11
   Web of Science ®Google Scholar
• Thornley T, Esquivel B, Wright DJ, Dop HV, Kirkdale CL, Youssef E. Implementation of a pharmacogenomic testing service through community pharmacy in the Netherlands: results from an early service evaluation. Pharmacy. 2021;9(1):38.
   Web of Science ®Google Scholar
• Gibson ML, Hohmeier KC, Smith CT. Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay. Pharmacogenomics. 2017;18(3):227–233.
   PubMed Web of Science ®Google Scholar
• McCullough KB, Formea CM, Berg KD, Burzynski JA, Cunningham JL, Ou NN, Rudis MI, Stollings JL, Nicholson WT. Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ. 2011;75(3):51.
   PubMed Web of Science ®Google Scholar
• Yau A, Abd Aziz AB, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharmacists. 2015;7(3).
   Google Scholar
• Petit C, Croisetière A, Chen F, Laverdière I. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice. Pharmacogenomics. 2020;21(4):247–256.
   PubMed Web of Science ®Google Scholar
• O’Connor SK, Ferreri SP, Michaels NM, Chater RW, Viera AJ, Faruki H, McLeod HL, Roederer M. Making pharmacogenetic testing a reality in a community pharmacy. J Am Pharm Assoc. 2012;52(6):e259–e265.
   Google Scholar
• Chukwu OA. Beyond medicines provision: community pharmacists roles in meeting patient needs through value-added pharmacy services. J Pharm Health Serv Res. 2020;11(3):299–301.
   Google Scholar
• Ihekoronye MR, Osemene KP, Erhun WO, Afolabi MO. Qualitative analysis of strengths, weaknesses, opportunities and threats of professional services by community pharmacies in Nigeria. J Health Med Sci. 2020;3(4).
   Google Scholar
• Nwafor OI, Ogbonna BO, Eze UI. Pharmaceutical care practices among registered community pharmacists in a state in southeast Nigeria: a frontier dynamics assessment. MOJ Public Health. 2019;8(5):198–205.
   Google Scholar
• Akande-Sholabi W, Adebisi YA. Toward pharmacy-based smoking cessation services in Nigeria: knowledge, perception and practice of community pharmacists. Popul Med. 2021;3(January):1–9.
   Google Scholar
• Bolaji OO, Adehin A, Adeagbo BA. Pharmacogenomics in the Nigerian population: the past, the present and the future. Pharmacogenomics. 2019;20(12):915–926.
   PubMed Web of Science ®Google Scholar
• Bunu SJ, Owaba AD, Vaikosen EN, Ebeshi BU. The Cyp2b6 gene polymorphism and phenotypic correlation of Efavirenz-based combination therapy among the Niger delta ethnic population: implications in modern pharmacogenomics. Pharmacogenomics Pers Med. 2022;15:45
   PubMed Web of Science ®Google Scholar
• Hassan MO, Duarte R, Mabayoje VO, Dickens C, Lasisi AO, Naicker S. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study. BMC Nephrol. 2020;21(1):1–9.
   Web of Science ®Google Scholar
• Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists. J Am Pharm Assoc. 2014;54(5):510–517.
   Google Scholar
• Algahtani M. Knowledge, perception, and application of pharmacogenomics among hospital pharmacists in Saudi Arabia. Risk Manag Healthc Policy. 2020;13:1279
   PubMed Web of Science ®Google Scholar
• Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Pers Med. 2013;10(8):793–800.
   PubMed Web of Science ®Google Scholar
• Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Q Atar. J Eval Clin Pract. 2015;21(4):703–709.
   PubMed Web of Science ®Google Scholar
• Ekpenyong A, Udoh A, Kpokiri E, Bates I. An analysis of pharmacy workforce capacity in Nigeria. J Pharm Policy Pract. 2018;11(1):1–9.
   PubMedGoogle Scholar
• Albassam A, Alshammari S, Ouda G, Koshy S, Awad A. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait. PLoS ONE. 2018;13(9): e0203033.
   PubMed Web of Science ®Google Scholar
• Surofchy DD, Mnatzaganian CL, Sarino LV, Kuo GM. Perceptions and attitudes of pharmacogenomics through the lens of community pharmacists and patients. J Contemp Pharm Pract. 2021;68(1):21–30.
   Google Scholar
• Bannur Z, Bahaman S, Salleh MZ, Teh LK. Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. IIUM Med J Malaysia. 2014;13(1).
   Google Scholar
• Seid MA, Hussen MS. Knowledge and attitude towards antimicrobial resistance among final year undergraduate paramedical students at University of Gondar, Ethiopia. BMC Infect Dis. 2018;18(1):1–8.
   PubMedGoogle Scholar
• Nagy M, Eirini Tsermpini E, Siamoglou S, Patrinos GP. Evaluating the current level of pharmacists’ pharmacogenomics knowledge and its impact on pharmacogenomics implementation. Pharmacogenomics. 2020;21(16):1179–1189.
   PubMed Web of Science ®Google Scholar
• Bagher AM, Neamatallah T, Balto G, Almikhy L, Almutairi SS, Abushal MO, Baghlaf K, Bagher SM. Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia. Saudi Pharm J. 2021;29(1):53–58.
   PubMed Web of Science ®Google Scholar
• Karuna N, Tragulpiankit P, Mahasirimongkol S, Chumnumwat S. Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand. Pharmacogenet Genomics. 2020;30(4):73–80.
   PubMed Web of Science ®Google Scholar
• Jarrar Y, Musleh R, Ghanim M, AbuKhader I, Jarrar Q. Assessment of the need for pharmacogenomics education among pharmacists in the West Bank of Palestine. Int J Clin Pract. 2021;75(9): e14435.
   PubMed Web of Science ®Google Scholar
• Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013;94(3):317–323
   PubMed Web of Science ®Google Scholar
• Matic M, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJ, Mulder H, Rongen GA, Weide JV, Wilffert B, Swen JJ. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Human Genet. 2021:1–9.
   Google Scholar